Bio-Vascular buys MCA (Medical Companies Alliance) for its anastomotic coupler
This article was originally published in Clinica
Bio-Vascular, which develops biomaterials and microwire components for interventional cardiovascular and neurological devices, has bought Medical Companies Alliance (MCA)'s stock for an undisclosed amount.
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.